IBDEI30F ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48066,0)
 ;;=E11.638^^185^2417^35
 ;;^UTILITY(U,$J,358.3,48066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48066,1,3,0)
 ;;=3^Diabetes Type 2 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,48066,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,48066,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,48067,0)
 ;;=E11.628^^185^2417^49
 ;;^UTILITY(U,$J,358.3,48067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48067,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Complications
 ;;^UTILITY(U,$J,358.3,48067,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,48067,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,48068,0)
 ;;=E11.630^^185^2417^36
 ;;^UTILITY(U,$J,358.3,48068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48068,1,3,0)
 ;;=3^Diabetes Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,48068,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,48068,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,48069,0)
 ;;=E11.8^^185^2417^53
 ;;^UTILITY(U,$J,358.3,48069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48069,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,48069,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,48069,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,48070,0)
 ;;=E11.9^^185^2417^54
 ;;^UTILITY(U,$J,358.3,48070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48070,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,48070,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,48070,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,48071,0)
 ;;=E11.36^^185^2417^9
 ;;^UTILITY(U,$J,358.3,48071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48071,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,48071,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,48071,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,48072,0)
 ;;=E11.22^^185^2417^10
 ;;^UTILITY(U,$J,358.3,48072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48072,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,48072,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,48072,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,48073,0)
 ;;=E11.29^^185^2417^12
 ;;^UTILITY(U,$J,358.3,48073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48073,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,48073,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,48073,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,48074,0)
 ;;=E11.21^^185^2417^13
 ;;^UTILITY(U,$J,358.3,48074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48074,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,48074,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,48074,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,48075,0)
 ;;=E11.39^^185^2417^16
 ;;^UTILITY(U,$J,358.3,48075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48075,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,48075,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,48075,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,48076,0)
 ;;=Z72.4^^185^2417^55
 ;;^UTILITY(U,$J,358.3,48076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48076,1,3,0)
 ;;=3^Diet & Eating Habits,Inappropriate
 ;;^UTILITY(U,$J,358.3,48076,1,4,0)
 ;;=4^Z72.4
 ;;^UTILITY(U,$J,358.3,48076,2)
 ;;=^5063257
 ;;^UTILITY(U,$J,358.3,48077,0)
 ;;=R68.81^^185^2417^56
 ;;^UTILITY(U,$J,358.3,48077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48077,1,3,0)
 ;;=3^Early Satiety
 ;;^UTILITY(U,$J,358.3,48077,1,4,0)
 ;;=4^R68.81
 ;;^UTILITY(U,$J,358.3,48077,2)
 ;;=^5019554
